"What's New in Research" sheds light on new work by Aditi Hazra, PhD, MPH, Katarzyna Karwacz, PhD, and Francisco Marty, MD.
BWHers share insights into what fields are growing and the trajectory of careers in biomedicine.
Oliver Jonas, PhD, MA, has developed a tiny device, smaller than a grain of rice, that releases small doses of anti-cancer therapies into tumors.
BWH Bookshelf recaps "Emergency Radiology COFFEE Case Book: Case-Oriented Fast Focused Effective Education" and "Chordomas: Technologies, Techniques and Treatment Strategies."
Program will bring together scientific and administrative staff at both hospitals to facilitate cancer research at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC).
Database will give BWH and Dana-Farber clinicians the ability to look at cancer outcomes at the hospitals and around the country.
Dr. Sandro Santagata explores the ancient cellular survival pathways co-opted by cancer.
A research team led by Karen Cichowski, PhD, and Thomas DeRaedt, PhD, BWH Division of Genetics,…
A study led by Christine G. Lian, MD, BWH Department of Pathology, suggests that the presence of…
The Cardio-Oncology Program, a joint collaboration between BWH and Dana-Farber Cancer Institute, focuses on the cardiovascular side effects of cancer therapy while maximizing cardiovascular outcomes for cancer survivors.
learned from studying HPV-associated cancers can also be applied to other tumor types
More than 60 multidisciplinary stakeholders develop recommendations to streamline the pathways for lung cancer care.
Raphael Bueno, MD performed the first successful iVATS case in the world earlier this year.
Researchers have transitioned Profile®, one of the nation’s most comprehensive personalized medicine initiatives in cancer.